M Duffaut

1.6k total citations
49 papers, 1.2k citations indexed

About

M Duffaut is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, M Duffaut has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 28 papers in Hepatology and 9 papers in Rheumatology. Recurrent topics in M Duffaut's work include Hepatitis C virus research (24 papers), Liver Disease Diagnosis and Treatment (16 papers) and Hepatitis B Virus Studies (15 papers). M Duffaut is often cited by papers focused on Hepatitis C virus research (24 papers), Liver Disease Diagnosis and Treatment (16 papers) and Hepatitis B Virus Studies (15 papers). M Duffaut collaborates with scholars based in France, Switzerland and United States. M Duffaut's co-authors include Jacques Izopet, Lionel Rostaing, J Puel, Laurent Alric, D. Durand, M. Abbal, Jean‐Marc Cisterne, E. Baron, D Durand and M. Fort and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Virology.

In The Last Decade

M Duffaut

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Duffaut France 16 971 827 158 138 108 49 1.2k
Fredric Regenstein United States 16 1.1k 1.1× 1.0k 1.2× 61 0.4× 72 0.5× 117 1.1× 33 1.3k
Hervé Zylberberg France 15 879 0.9× 820 1.0× 67 0.4× 44 0.3× 219 2.0× 21 1.2k
M. Gigou France 20 1.8k 1.8× 1.6k 1.9× 58 0.4× 83 0.6× 113 1.0× 37 2.0k
P. Chossegros France 12 805 0.8× 761 0.9× 113 0.7× 36 0.3× 46 0.4× 42 1.0k
Catherine Edwards-Smith Australia 7 422 0.4× 391 0.5× 92 0.6× 40 0.3× 29 0.3× 10 832
V. Carreño Spain 19 880 0.9× 864 1.0× 79 0.5× 22 0.2× 98 0.9× 66 1.1k
Montserrat Garcı́a-Retortillo Spain 17 1.6k 1.6× 1.4k 1.7× 34 0.2× 60 0.4× 73 0.7× 52 1.7k
J H Hoofnagle United States 17 1.5k 1.5× 1.4k 1.7× 70 0.4× 19 0.1× 162 1.5× 23 1.9k
F. Tremolada Italy 19 1.6k 1.7× 1.6k 2.0× 89 0.6× 12 0.1× 115 1.1× 43 1.8k
Laure Elkrief France 18 1.1k 1.2× 1.2k 1.4× 34 0.2× 33 0.2× 77 0.7× 45 1.5k

Countries citing papers authored by M Duffaut

Since Specialization
Citations

This map shows the geographic impact of M Duffaut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Duffaut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Duffaut more than expected).

Fields of papers citing papers by M Duffaut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Duffaut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Duffaut. The network helps show where M Duffaut may publish in the future.

Co-authorship network of co-authors of M Duffaut

This figure shows the co-authorship network connecting the top 25 collaborators of M Duffaut. A scholar is included among the top collaborators of M Duffaut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Duffaut. M Duffaut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delobel, Pierre, et al.. (2005). Transient clonal expansion of T-large granular lymphocytes during primary cytomegalovirus infection. Journal of Infection. 53(2). e65–e67. 10 indexed citations
2.
Kamar, Nassim, Karine Sauné, David Ribes, et al.. (2004). Effects of long-term lamivudine therapy in renal-transplant patients. Journal of Clinical Virology. 31(4). 298–303. 17 indexed citations
3.
Kamar, Nassim, Bernard Malavaud, Laurent Alric, et al.. (2003). Ureteral stenosis as the sole manifestation of Wegener’s granulomatosis. Urology. 62(2). 352–352. 11 indexed citations
4.
Alric, Laurent, Vincent Di Martino, P. Cacoub, et al.. (2002). Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection. Gastroenterology. 123(5). 1494–1499. 84 indexed citations
5.
Alric, Laurent, et al.. (2001). Association entre un lupus érythémateux disséminé et une maladie de Crohn. La Revue de Médecine Interne. 22(4). 385–388. 8 indexed citations
6.
Izopet, Jacques, Lionel Rostaing, Karine Sandres, et al.. (2000). Longitudinal Analysis of Hepatitis C Virus Replication and Liver Fibrosis Progression in Renal Transplant Recipients. The Journal of Infectious Diseases. 181(3). 852–858. 66 indexed citations
7.
Alric, Laurent, Claudine Orfila, Nicolas Carrère, et al.. (2000). Reactive oxygen intermediates and eicosanoid production by Kupffer cells and infiltrated macrophages in acute and chronic liver injury induced in rats by CCl 4. Inflammation Research. 49(12). 700–707. 48 indexed citations
8.
Alric, Laurent, et al.. (2000). Association entre polymyosite et infection par le virus de l'hépatite C. Les difficultés du traitement. La Revue de Médecine Interne. 21(6). 542–546. 11 indexed citations
9.
Rostaing, Lionel, Jacques Izopet, Catherine Arnaud, et al.. (1999). LONG-TERM IMPACT OF SUPERINFECTION BY HEPATITIS G VIRUS IN HEPATITIS C VIRUS-POSITIVE RENAL TRANSPLANT PATIENTS. Transplantation. 67(4). 556–560. 12 indexed citations
10.
Alric, Laurent, Jacques Izopet, Marylise Fort, et al.. (1999). Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection. Human Immunology. 60(6). 516–523. 30 indexed citations
11.
Izopet, Jacques, Lionel Rostaing, Martine Dubois, et al.. (1997). Kinetics of HCV Viremia in Kidney Transplant Recipients During and After α-lnterf eron Therapy. American Journal of Nephrology. 17(5). 417–420. 9 indexed citations
12.
Rostaing, Lionel, Sabine Henry, Jean‐Marc Cisterne, et al.. (1997). EFFICACY AND SAFETY OF LAMIVUDINE ON REPLICATION OF RECURRENT HEPATITIS B AFTER CADAVERIC RENAL TRANSPLANTATION. Transplantation. 64(11). 1624–1627. 89 indexed citations
13.
Tubéry, M., et al.. (1996). Kikuchi's disease, Hashimoto's thyroiditis and lupus auto-antibodies. A case report.. La Revue de Médecine Interne. 10(17). 836–838. 2 indexed citations
14.
Alric, Laurent, Éric Pinelli, G. Carrera, et al.. (1996). Involvement of calcium in macrophage leukotriene release during experimental cirrhosis. Hepatology. 23(3). 614–622. 12 indexed citations
15.
Rostaing, Lionel, Jacques Izopet, Jean‐Marc Cisterne, et al.. (1996). Treatment of Chronic Hepatitis B and C with Alpha Interferon in a Renal Transplant Patient. Scandinavian Journal of Urology and Nephrology. 30(6). 485–487. 4 indexed citations
16.
Rostaing, Lionel, Jacques Izopet, Emmanuel Baron, et al.. (1996). Epidemiology of HCV infection: disease and renal transplantation. Nephrology Dialysis Transplantation. 11(supp4). 46–47. 8 indexed citations
17.
Rostaing, Lionel, Jacques Izopet, E. Baron, et al.. (1995). TREATMENT OF CHRONIC HEPATITIS C WITH RECOMBINANT INTERFERON ALPHA IN KIDNEY TRANSPLANT RECIPIENTS. Transplantation. 59(10). 1426–1431. 148 indexed citations
18.
Arlet, P., et al.. (1981). [Circulating anticoagulant during primosecondary syphilis and Q fever].. PubMed. 10(35). 2909–2909. 2 indexed citations
19.
Ribet, A, et al.. (1976). Use of caerulein with submaximal doses of secretin as a test of pancreatic function in man.. Gut. 17(6). 431–434. 32 indexed citations
20.
Orfila, Claudine, et al.. (1976). [Localization of HBsAg, immunoglobulins, fibrin and C3 in the liver by direct immunoflourescence].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 24(5). 313–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fredric Regenstein Breakdown of academic impact, for papers by Hervé Zylberberg Breakdown of academic impact, for papers by M. Gigou Breakdown of academic impact, for papers by P. Chossegros Breakdown of academic impact, for papers by Catherine Edwards-Smith Breakdown of academic impact, for papers by V. Carreño Breakdown of academic impact, for papers by Montserrat Garcı́a-Retortillo Breakdown of academic impact, for papers by J H Hoofnagle Breakdown of academic impact, for papers by F. Tremolada Breakdown of academic impact, for papers by Laure Elkrief
Rankless by CCL
2026